Its role Owner
Solar International Core Canada Ltd. is a privately held Canadian company incorporated in November 2024 under the Canada Business Corporations Act. Headquartered in Toronto, Ontario, the firm is engaged in the pharmaceutical sector, with a focus on the production of active pharmaceutical ingredients (APIs) and generic medications.
The company's flagship initiative is a major investment project in Mexico. In May 2026, it signed a memorandum of understanding with the state of Hidalgo to develop an API manufacturing facility in the Zapotlán Economic Development Hub. The planned investment totals approximately US$2 billion, including US$70 million allocated for land acquisition. The plant is expected to generate around 1,700 direct jobs and commence operations by 2028.
Led by CEO Babak Arefpour, with directors Behzad Sharifi Kalangestani and Aboohamid Ehsani-Armaki, the company operates as an independent entity. It has no publicly disclosed affiliations with larger corporate groups. Through this venture, Solar International Core Canada aims to establish a presence in the global API supply chain, supporting pharmaceutical manufacturing in North America and contributing to industrial growth in Mexico's chemical and life sciences industries.
The project aligns with broader efforts in chemical manufacturing, as APIs represent specialized chemical production. The company is also referenced in contexts involving energy and battery-related records, though its primary announced activities center on pharmaceuticals.
Also known as DUGM SOLAR INTERNATIONAL Ltd. and Zapotlán Solar International API.
chemXplore tracks 1 project involving SICC, of which one is active.
active all projects
